Key Trends in 2018 in the Biopharmaceutical Market
Interview with Nigel Darby, Advisor, GE Healthcare Life Sciences
The Challenge of Immunotherapy: Staying on Target
Immunotherapies Can Produce Side Effects That Mimic Autoimmune Diseases
Vaccine Industry Retools Itself for Speed
Vaccine Manufacturing Moves toward Mass Customization
Toward a Universal Flu Vaccine
New Candidate Fights Back against the Flu’s Efforts to Undermine the Human Immune System
For full access to this article login to GEN Select now.
Better, Earlier ADME/Tox Predictions in Cells
- Whole-animal models are still the gold standard for toxicity predictions and are required by regulatory agencies, yet for many biological pathways and mechanisms they do not provide a good extrapolation to humans. In vitro surrogate assays provide more representative methods to rule out adverse effects early in the ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.